Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SGMO - Sangamo Therapeutics Announces Participation at Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease

SGMO - Sangamo Therapeutics Announces Participation at Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease

Sangamo Therapeutics Inc.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in the virtual Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare Disease conference on April 1, 2021. Sangamo management is expected to participate in a panel discussion at 10 a.m. Eastern Time on April 1, 2021.

The event will be webcast live and available via an access link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations . The event will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005156/en/

Investor Relations & Media Inquiries
Aron Feingold
628.252.7494
afeingold@sangamo.com

Stock Information
Company Name: Sangamo Therapeutics Inc.
Stock Symbol: SGMO
Market: NASDAQ
Website: sangamo.com
Menu
SGMO SGMO Quote SGMO Short SGMO News SGMO Articles SGMO Message Board
Get SGMO Alerts

News, Short Squeeze, Breakout and More Instantly...